NCT06349902 is a clinical trial of Re-Link in Hepatitis C, sponsored by trueNorth Medical Centres.

Who is sponsoring NCT06349902?

NCT06349902 is sponsored by trueNorth Medical Centres.

What drugs are being tested in NCT06349902?

Interventions in NCT06349902: Re-Link.

What condition does NCT06349902 study?

NCT06349902 studies Hepatitis C.

Is NCT06349902 still recruiting?

NCT06349902 is currently status unknown. Last updated 5 April 2024.

Last reviewed 2024-04-05 · How we verify

NCT06349902

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Re-link HCV in Substance-Use Telemedicine Program

Status unknown Last updated 5 April 2024

What this trial tests

trial testing Re-Link in Hepatitis C in 5,000 participants. Status unknown.

Timeline

12 March 2024

Primary endpoint
31 August 2024

31 December 2024

Quick facts

Lead sponsor	trueNorth Medical Centres
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	5,000
Start date	12 March 2024
Primary completion	31 August 2024
Estimated completion	31 December 2024
Sites	1 location across Canada

Drugs / interventions tested

Re-Link

Conditions studied

Hepatitis C — all drugs for Hepatitis C →

Sponsor

trueNorth Medical Centres

Who can join

Eligibility, any sex, with Hepatitis C. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational, retrospective \& prospective cohort study. The retrospective element of the study is a chart review to identify people with diagnosed but untreated HCV and re-link them to care. The observational prospective cohort element of the study will examine the HCV linkage to care, treatment initiation, treatment completion \& cure rates of these HCV clients achieved through this chart review and re-linking approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hepatitis C

Currently open trials in the same condition.

NCT06263829 — HCV Tappt Adherence Study · NA · recruiting
NCT06179498 — Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs · NA · recruiting
NCT06367465 — Feasibility and Acceptability of HCV Treatment in Pregnancy · recruiting
NCT05668780 — Buprenorphine Integration Research and Community Health · NA · active not recruiting
NCT05208697 — Tele-Harm Reduction · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06349902 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by trueNorth Medical Centres
Last refreshed: 5 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06349902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing